Not investment advice. Origin reports data from public SEC filings with cryptographic provenance. No buy/sell/hold recommendations. Past performance does not indicate future results.
## JPMorgan Surges 17% to $349 Since May as Query Volume Triples to 613, Shifting the Burden of Proof to Expense Execution
From the May 12 baseline at $300 through the May 25 check at $306, the stock has now extended materially to $349.67 — a 17% move in roughly four months that has compressed the margin-of-safety cushion the market previously offered against the $91.5B expense guide risk flagged in prior observations. The core tension identified in May — expense creep versus revenue trajectory — has not resolved; it has simply been repriced upward. Origin AI query volume has tripled from 200 to 613 all-time since the May 25 observation, reflecting sustained and accelerating analytical scrutiny on this name at a moment when the stock offers less forgiveness for execution misses. The filing signal profile remains unchanged: 131 risk factor matches in the latest 10-K, 26 strategic event matches, and 10 AI adoption matches. What matters now is whether the strategic and AI adoption signals (platform_shift showing 6, 6, and 5 matches across categories) are beginning to translate into measurable revenue contribution, or whether they remain narrative positioning. Management's "upbeat" tone on normalization and the 30-40 basis point annual share growth target look more credible at $349 only if the $91.5B expense guide holds firm and CD repricing flows through NII as projected. Key variables heading into the next earnings cycle: whether expense guidance holds or prints above $91.5B, evidence of loan volume recovery beyond payoff-offset activity, and any quantifiable AI monetization disclosure that justifies the platform_shift signal density in the filings.
## JPMorgan Surges to $362 as Query Volume Hits 513 — Market Re-Rates Execution Confidence While Expense Watch Continues
The stock's move from $306 to $362.84 since the May 25 observation represents a 18.4% gain in roughly eleven weeks — a significant re-rating that appears to reflect either positive earnings developments not yet captured in the transcript signals, or broader market momentum lifting large-cap financials. The $832B market cap holds steady, suggesting share count stability. Meanwhile, Origin AI query volume has grown from 200 to 513 all-time — a 157% increase since May 25 — indicating this name is attracting substantially more analytical scrutiny, consistent with a stock that has moved materially and requires fresh thesis-testing. The core tension flagged in prior observations remains unresolved in the available data: the $91.5B expense guide, muted near-term loan growth, and CD balance repricing dynamics are still the operative signals from the transcript layer. No new transcript facts have entered the record since May 12, which means the market's re-rating to $362 is outpacing the observable fundamental narrative. That divergence is itself a data point — either earnings calls since May have delivered upside surprises that haven't yet registered in the captured transcript set, or the stock is running on macro tailwinds. Key items to watch in the next cycle: whether the August earnings transcript (Q2 2026 results) updates the expense guide above or below $91.5B, whether loan origination volumes show early signs of recovering from the payoff-offset dynamic, and whether the 513 query volume corresponds to new institutional positioning. The $362 price demands execution follow-through.
## JPMorgan Surges 15% to $353 Since May as Query Volume Hits 358 and Market Reprices Execution Confidence Higher
The $53 move from $300 to $353.21 since the initial May 12 observation — roughly 17.7% in approximately ten weeks — represents a significant re-rating that has outpaced the cautious operational tone flagged in prior observations. Recall that the May 12 update explicitly flagged margin compression risk from the $91.5B expense guide and muted near-term loan growth; the market appears to have discounted those headwinds and is instead pricing the "upbeat" management narrative more aggressively. At $353 and $832B market cap, the valuation now demands cleaner execution on the expense line. Any upward revision to the $91.5B guide would carry more asymmetric downside than it would have at $300. Origin AI query volume reaching 358 all-time — up from 200 at the May 25 observation — confirms sustained and accelerating analytical attention. The signal profile in the 10-K remains weighted heavily toward risk (131 matches in the primary category, plus 19 and 3 in sub-categories), while AI adoption remains relatively thin at 10 matches. This disconnect between market enthusiasm and filing-level risk density is worth monitoring carefully heading into the next earnings cycle. Key variables to track: whether CD balance repricing flows through NII as management projected with "pretty high betas," whether the $91.5B expense figure holds given inflationary pressures across compensation and technology investment, and whether the 30-40 basis point annual share growth targets in specific business lines begin producing observable volume signals in transcript data.
## JPMorgan Surges 14% to $343 Since May 12 as Query Volume Hits 335 and Market Re-rates Execution Confidence
The price action since the May 12 observation has been striking: JPM has climbed from $300 to $343.15, a 14% move in approximately 65 days, pushing market cap well beyond the $832B figure cited in prior observations. This re-rating has occurred against an unchanged operational narrative — the $91.5B expense guide, muted near-term loan growth, and CD balance repricing dynamics flagged in May remain the same disclosed facts. The market appears to be pricing forward normalization more aggressively than management's own "somewhat challenged" guidance language would suggest. That divergence between price momentum and operational caution is the central tension worth monitoring. Origin AI query volume has grown from 105 on May 12 to 335 today — a 219% increase in roughly 65 days — confirming accelerating analytical attention on this name. With 253 transcripts now captured, the signal base is deepening, yet the filing signal profile remains unchanged: 131 risk factor matches dominate, while AI adoption (10 matches) and growth inflection (8 matches) signals remain comparatively thin. The market is running ahead of where the documentary evidence sits. Key watch items into the next earnings cycle: whether $343 can hold if the $91.5B expense guide creeps higher, how aggressively CD repricing flows through NII as balances peak, and whether the "30 to 40 basis point" annual share growth targets begin generating harder transcript confirmation. At current levels, execution margin for error has narrowed considerably.
## JPMorgan Surges 12% to $342 Since May 12 as Query Volume Triples and Expense Discipline Remains the Fulcrum
Since the May 12 observation established $300 as the baseline and flagged the $91.5B expense guide as the central margin risk, JPM has appreciated roughly 14% to $342.89 — a meaningful move that has outpaced the cautious operational tone embedded in management's own transcript language. The stock now implies even greater execution confidence than the $832B market cap did six weeks ago. Origin AI query volume has tripled from 105 to 334 in approximately 60 days, a velocity that suggests this name is attracting sustained systematic analytical attention rather than episodic interest. With 253 transcripts captured, the signal base is deep. The core tension flagged in prior observations remains unresolved: management language is simultaneously upbeat on normalization and explicit about near-term headwinds — muted loan growth as originations are offset by payoffs, CD balances peaking around now before repricing lower with "pretty high betas," and results expected to be "somewhat challenged." None of that narrative has changed. What has changed is price — which means the market is either pricing in a faster normalization timeline than management guided, or the broader rate and macro environment has shifted favorably enough to override the caution. The next critical datapoints: whether Q2 earnings (likely mid-July) show the $91.5B expense guide holding, whether NII inflects as CD repricing flows through, and whether loan origination volumes finally exceed payoff activity. A miss on any of these against a 14% run would be asymmetric.
## JPMorgan Surges 11% to $334 Since May as Query Volume Hits 334 and Market Conviction Outpaces Operational Clarity
The stock has now moved from $300 on May 12 to $334.53 as of July 13 — an 11.5% gain in roughly two months — while the underlying operational narrative has remained largely unchanged. The $91.5B expense guide flagged in the first observation still stands, CD balances are still expected to peak and reprice with "pretty high betas," and loan growth remains muted with originations offset by payoffs. The market is clearly pricing in something beyond the current income statement — likely a combination of rate environment optimism and JPM's structural positioning as the dominant U.S. money-center franchise. At $832B market cap and $334/share, the premium for execution confidence has widened, not narrowed. Origin AI query volume reaching 334 all-time — up from 200 on May 25 and 105 on May 12 — traces a near-linear acceleration in analytical attention, roughly doubling every two weeks. This is worth noting as a sentiment signal independent of price: sustained query growth often precedes either a catalyst or a crowding dynamic. The filing signal profile remains static, with 131 risk factor matches still dominating the 10-K landscape versus 10 AI adoption and 8 growth inflection matches. The central watch items heading into the next earnings cycle remain consistent: does the $91.5B expense line hold, does NII compress as CD repricing flows through, and does loan volume recovery materialize to validate management's "upbeat" tone on normalization? The gap between price momentum and operational uncertainty is now the defining tension on this name.
## JPMorgan Surges 12% to $336 Since May as Query Volume Hits 330 and Expense Discipline Remains the Linchpin
The price action since the May 12 observation has been materially stronger than the operational narrative alone would suggest. JPM has moved from $300 to $336.47 — a 12% gain in roughly two months — while the fundamental signals captured across 253 transcripts remain largely unchanged: $91.5B expense guide intact, muted near-term loan growth, and CD balances "peaking around now" before repricing lower. The disconnect between price appreciation and unchanged operational guidance is worth flagging explicitly. The market appears to be pricing forward normalization optimism ahead of confirmation. Origin AI query volume reaching 330 all-time — up from 200 just weeks ago — reflects the same dynamic: analytical attention is accelerating even as the underlying data points hold steady. The 131 risk factor matches in the 10-K remain the dominant filing signal, still outnumbering strategic and AI adoption signals (26 and 10 respectively) by a wide margin. The 8 growth_inflection matches remain a watch item for whether management's "upbeat" tone on normalization converts to measurable loan volume recovery. The critical verification moment is the next earnings cycle. Three specific tests will either validate or challenge the current market premium: whether the $91.5B expense guide holds or creeps higher under ongoing investment pressure, whether CD repricing flows through NII as constructively as management implied, and whether the 30-to-40 basis point annual share growth targets in specific business lines show early traction. At $832B market cap, the execution bar is unambiguous.
## JPMorgan Surges 12% to $336 Since May 12 as Query Volume Triples and Market Pricing Runs Ahead of Operational Clarity
The price action since the initial May 12 observation has been striking: JPM has moved from $300 to $336.47, a 12% gain in roughly two months, pushing market cap well above $832B while the operational data points flagged in prior observations remain largely unresolved. The $91.5B expense guide is unchanged, loan growth remains muted with originations still offset by payoffs, and CD balances are described as peaking "around now" — exactly the dynamic flagged on May 12 as a margin compression risk. The market has re-rated the stock materially without a visible catalyst in the transcript or filing signal profile, which warrants scrutiny. Origin AI query volume tells a parallel story: 105 queries at the first observation, 200 by May 25, now 329 — a tripling in under two months. Transcript capture has reached 253. Analytical attention is compounding, but the filing signal composition is static: 131 risk factor matches still dominate, with AI adoption (10 matches) and growth inflection (8 matches) representing the more constructive signals that may be driving sentiment. The central tension now is whether the $336 price level is anticipating a clean Q2 earnings beat — particularly on NII recovery as CD repricing works through — or whether it has simply moved with broader market momentum. Key watches: Q2 earnings confirmation of expense discipline at or below $91.5B, any revision to the loan growth outlook, and whether management tone shifts from "upbeat" to quantifiably improved on originations.
## JPMorgan Surges 10% to $329 as Query Volume Climbs to 275 — Expense Discipline and NII Trajectory Now the Defining Variables
Since the May 25 observation noted a modest 2% drift to $306, JPM has accelerated sharply to $329.05 — a roughly 7.5% move in approximately one month, pushing the stock well above the $300 baseline established in the May 12 observation and adding meaningful implied value against the $832B market cap. The move is notable precisely because the operational narrative has not materially changed: the $91.5B expense guide holds, loan growth remains muted with originations offset by payoffs, and CD repricing is still expected to work through the system with "pretty high betas." The market appears to be pricing in normalization confidence ahead of confirmation. Origin AI query volume has grown to 275 all-time, a measured increase from the 200 logged on May 25, suggesting analytical attention is broadening but not yet spiking — consistent with accumulation behavior rather than event-driven noise. The filing signal profile remains unchanged at 131 risk factor matches against 26 strategic event and 10 AI adoption signals, meaning no new material disclosure has shifted the structural picture. The "30 to 40 basis points average annual share growth" commentary referenced across observations continues to anchor near-term expansion expectations as deliberately measured. Key variables sharpening into focus for the next earnings cycle: whether the $91.5B expense guide holds under revenue pressure, how aggressively CD balances reprice lower, and whether loan origination volume finally breaks above payoff headwinds to produce net growth. A continued stock advance without NII improvement would widen the gap between price and operational confirmation.
## JPMorgan Surges 12% to $335 as Query Volume Climbs to 270 and Expense Discipline Remains the Unresolved Variable
Since the May 25 observation captured JPM at $306 with 200 Origin AI queries, the stock has added another ~9.4% to reach $335.12 — a cumulative 12% move from the $300 level flagged in the original May 12 expense-guide observation. That's a meaningful re-rating in roughly six weeks, with the $832B market cap holding steady, implying the share count hasn't materially shifted. Query volume has climbed again to 270, continuing the acceleration trend (105 → 200 → 270) that has tracked closely with price momentum. Whether that correlation is causal or coincidental is worth monitoring. The operational data, however, remains unchanged from prior observations: the $91.5B expense guide is still the central watch item, loan growth is still described as "muted" with originations offset by payoffs, and CD balances are characterized as "peaking around now" with high betas on the way down. None of that has materially improved in the transcript record — which makes the 12% price appreciation notable. The market appears to be pricing in the normalization narrative management called "upbeat," ahead of confirmation in actual NII or volume data. The critical next checkpoint is whether Q2 earnings validate the $91.5B expense ceiling or revise it higher, and whether CD repricing actually flows through to NII improvement as expected. The 131 risk-factor matches in the 10-K remain a structural backdrop. A gap between management tone and reported results would be a significant signal shift given current valuation levels.
## JPMorgan Surges to $325 as Query Volume Plateaus and Expense Discipline Enters Execution Phase
The stock has moved from $306 to $325.22 since the May 25 observation — a 6.2% gain in roughly three weeks — extending the steady drift upward from $300 that began when this coverage chain opened on May 12. That cumulative 8.4% move against a largely unchanged fundamental narrative is worth flagging: the operational signals have not materially shifted. The $91.5B expense guide, muted near-term loan growth, CD balance peak timing, and "somewhat challenged" results commentary are all still in the transcript record verbatim. The market appears to be pricing forward normalization more aggressively than the cautious management tone warrants. Query volume tells a different story — growth has essentially stalled, with Origin AI queries moving only from 200 to 258 across the past three weeks after doubling in the prior ten-day window. That deceleration in analytical attention, coinciding with a sharp price move, is a mild divergence worth tracking. The filing signal profile remains static: 131 risk factor matches dominate, while AI adoption (10 matches) and growth inflection (8 matches) signals have not incremented, suggesting no new material filings have shifted the strategic narrative. Three variables remain the critical watch items heading into the next earnings cycle: whether the $91.5B expense guide holds as revenue confirmation or becomes a ceiling problem, whether loan origination volume begins outpacing payoffs to validate the "upbeat" normalization thesis, and whether CD repricing beta flows through NII in line with management's "pretty high betas" framing.
## JPMorgan Surges 10% to $331 Since May 12 as Query Volume Hits 252 and Expense Discipline Remains the Unresolved Variable
From the May 12 baseline observation at $300, JPM has now appreciated to $331.14 — a 10.4% move in roughly five weeks — with the market cap holding at $832B on share count adjustments. This price action outpaces the modest operational updates captured in the intervening observations: the $91.5B expense guide remains unchanged, CD balance repricing is still unfolding, and near-term loan growth remains self-described as "muted." The gap between price momentum and fundamental evolution is worth flagging explicitly. Either the market is front-running a cleaner-than-expected Q2 expense print, or multiple expansion is doing work that earnings haven't yet validated. The query volume trajectory remains a useful attention proxy: from 105 queries at May 12, to 200 at May 25, to 252 today — roughly 47 additional queries in the last three weeks after an initial doubling. The deceleration in query growth rate, even as price accelerated, may suggest analytical consensus is consolidating rather than fragmenting. Filing signal counts remain static (131 risk factor matches, 26 strategic event, 10 AI adoption), indicating no new 10-K filings have refreshed the underlying document signals. The critical watch items into Q2 earnings remain: whether adjusted expenses hold at or below $91.5B, whether CD repricing beta materializes as management guided, and whether "upbeat" language on normalization translates into measurable loan origination recovery. At $331, execution tolerance for any upward expense revision has narrowed considerably.
## JPMorgan's Query Surge to 200 Confirms Analyst Focus on Expense Discipline While $306 Price Holds the Execution Premium
Since the May 12 observation flagged the $91.5B expense guide as a live margin compression risk, JPM has drifted modestly from $300 to $306.38 — approximately 2.1% — against an essentially unchanged operational narrative. The more telling development is the doubling of Origin AI queries from 105 to 200 in roughly ten days, now supported by 253 transcripts captured. That acceleration in analytical attention typically precedes a catalyst, not follows one, suggesting market participants are actively building or stress-testing positions ahead of the next earnings cycle rather than reacting to new disclosures. The core tension flagged in prior observations remains unresolved: $91.5B in adjusted expenses running against muted near-term loan growth, CD balances peaking now before repricing lower with "pretty high betas," and originations still being offset by payoff activity. Management's "upbeat" tone on normalization is a narrative commitment that needs numerical validation. The 131 risk-factor matches in the 10-K remain the dominant filing signal, outnumbering growth_inflection (8 matches) and platform_shift (6-7 matches) by a substantial margin — the filing profile still reads more defensive than offensive despite strategic framing. At $832B market cap and $306.38, the execution premium is intact but not expanding. Watch for: any Q2 guidance revision on expenses relative to the $91.5B anchor, whether CD repricing materially impacts reported NII, and if loan origination volumes show any recovery from the offset-by-payoffs dynamic. A third consecutive query-volume surge on Origin would suggest external catalyst anticipation is building.
## JPMorgan Holds Steady at $306 as Query Volume Doubles and Expense Discipline Becomes the Central Watch Item
Since the May 12 observation flagged the $91.5B expense guide as a live margin compression risk, the stock has moved modestly from $300 to $306.38 — a roughly 2% drift upward against an unchanged operational narrative. More notable is the doubling of Origin AI queries from 105 to 200 in approximately ten days, signaling accelerating analytical attention on this name. With 253 transcripts now captured, the signal corpus is deepening, though the filing signal distribution remains unchanged from the prior read: 131 risk factor matches still dominate, while AI adoption (10 matches) and growth inflection (8 matches) remain secondary threads. The core tension identified in the prior observation has not resolved. Management's own language continues to reflect a bifurcated posture — "upbeat" on normalization trajectory while simultaneously guiding for muted near-term loan growth as originations are offset by payoffs. CD balances are described as peaking "around now," which means the repricing tailwind to NII is a forward, not current, benefit. The 30-to-40 basis point annual share growth target in specific business lines remains a measured ambition, not a breakout signal. At $832B market cap and $306.38, the market continues to price execution confidence ahead of confirmation. The next critical data point is whether Q2 transcript language shows any shift in loan volume momentum or whether expense guidance creeps above $91.5B — either development would materially test the current valuation multiple. Watch NII guidance revisions closely.
## JPMorgan Raises Expense Guidance to $91.5B as Growth Signals Remain Mixed Against $832B Market Cap
Building on the initial data refresh observation from May 12, this update captures a meaningful operational data point: JPM has revised its adjusted expense outlook upward to approximately $91.5 billion. This figure warrants close monitoring against revenue trajectory — particularly given that transcript signals simultaneously reference muted near-term loan growth, with originations largely offset by payoff activity, and CD balances expected to peak around the current period before repricing lower with "pretty high betas." These dynamics suggest margin compression pressure is live, not hypothetical. The filing signal profile remains dense on the risk side — 131-plus risk factor matches in the latest 10-K — while strategic and AI adoption signals (26 and 10 matches respectively) indicate management is actively framing forward positioning around platform evolution. The 8 growth_inflection and 6-plus platform_shift matches are worth tracking as leading indicators of whether JPM's strategic narrative is shifting from defense to offense. The share growth commentary referencing "30 to 40 basis points average annual" growth targets suggests measured, not aggressive, expansion expectations in specific business lines. At $300/share and $832B market cap, the market is pricing in considerable execution confidence. Key variables to watch in the next earnings cycle: whether the $91.5B expense guide holds or creeps higher, how CD repricing flows through NII, and whether the "upbeat" management tone on normalization is validated by loan volume recovery. The 105 Origin AI queries signal growing analytical attention on this name.